220 related articles for article (PubMed ID: 25298577)
1. Comparative cardiovascular safety of risperidone and olanzapine, based on electrocardiographic parameters and blood pressure: a prospective open label observational study.
Choure BK; Gosavi D; Nanotkar S
Indian J Pharmacol; 2014; 46(5):493-7. PubMed ID: 25298577
[TBL] [Abstract][Full Text] [Related]
2. Absence of Change in Corrected QT Interval in Children and Adolescents Receiving Antipsychotic Treatment: A 12 Month Study.
Alda JA; Muñoz-Samons D; Tor J; Merchán-Naranjo J; Tapia-Casellas C; Baeza I; Calvo-Escalona R; Castro-Fornieles J; Martínez-Cantarero C; Andrés-Nestares P; Fernández-Avilés F; Arango C
J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):449-57. PubMed ID: 26779966
[TBL] [Abstract][Full Text] [Related]
3. Changes in PR and QTc intervals after switching from olanzapine to risperidone in patients with stable schizophrenia.
Suzuki Y; Sugai T; Ono S; Sawamura K; Fukui N; Watanabe J; Tsuneyama N; Saito M; Someya T
Psychiatry Clin Neurosci; 2014 May; 68(5):353-6. PubMed ID: 24405493
[TBL] [Abstract][Full Text] [Related]
4. Switching patients with stable schizophrenia or schizoaffective disorder from olanzapine to risperidone long-acting injectable.
Rosa F; Schreiner A; Thomas P; Sherif T
Clin Drug Investig; 2012 Apr; 32(4):267-79. PubMed ID: 22339430
[TBL] [Abstract][Full Text] [Related]
5. Comparison of longer-term safety and effectiveness of 4 atypical antipsychotics in patients over age 40: a trial using equipoise-stratified randomization.
Jin H; Shih PA; Golshan S; Mudaliar S; Henry R; Glorioso DK; Arndt S; Kraemer HC; Jeste DV
J Clin Psychiatry; 2013 Jan; 74(1):10-8. PubMed ID: 23218100
[TBL] [Abstract][Full Text] [Related]
6. Long-term antipsychotic monotherapy for schizophrenia: disease burden and comparative outcomes for patients treated with olanzapine, quetiapine, risperidone, or haloperidol monotherapy in a pan-continental observational study.
Dossenbach M; Pecenak J; Szulc A; Irimia V; Anders M; Logozar-Perkovic D; Peciukaitiene D; Kotler M; Smulevich AB; West TM; Lowry AJ; Treuer T
J Clin Psychiatry; 2008 Dec; 69(12):1901-15. PubMed ID: 19012820
[TBL] [Abstract][Full Text] [Related]
7. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
8. Cardiovascular variability during treatment with haloperidol, olanzapine or risperidone in recent-onset schizophrenia.
Hempel RJ; Tulen JH; van Beveren NJ; Röder CH; Hengeveld MW
J Psychopharmacol; 2009 Aug; 23(6):697-707. PubMed ID: 18562420
[TBL] [Abstract][Full Text] [Related]
9. An open-label randomized comparison of olanzapine versus risperidone in the treatment of childhood-onset schizophrenia.
Mozes T; Ebert T; Michal SE; Spivak B; Weizman A
J Child Adolesc Psychopharmacol; 2006 Aug; 16(4):393-403. PubMed ID: 16958565
[TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
11. A 24-week, multicenter, open-label, randomized study to compare changes in glucose metabolism in patients with schizophrenia receiving treatment with olanzapine, quetiapine, or risperidone.
Newcomer JW; Ratner RE; Eriksson JW; Emsley R; Meulien D; Miller F; Leonova-Edlund J; Leong RW; Brecher M
J Clin Psychiatry; 2009 Apr; 70(4):487-99. PubMed ID: 19358783
[TBL] [Abstract][Full Text] [Related]
12. The impact of adjunctive aripiprazole on QT interval: A 12-week open label study in patients on olanzapine, clozapine or risperidone.
Pilunthanakul T; Ting MQJ; Lee J; Gupta B
Hum Psychopharmacol; 2023 May; 38(3):e2863. PubMed ID: 36810742
[TBL] [Abstract][Full Text] [Related]
13. Quetiapine versus other atypical antipsychotics for schizophrenia.
Asmal L; Flegar SJ; Wang J; Rummel-Kluge C; Komossa K; Leucht S
Cochrane Database Syst Rev; 2013 Nov; (11):CD006625. PubMed ID: 24249315
[TBL] [Abstract][Full Text] [Related]
14. ECG parameters in children and adolescents treated with aripiprazole and risperidone.
Germanò E; Italiano D; Lamberti M; Guerriero L; Privitera C; D'Amico G; Siracusano R; Ingrassia M; Spina E; Calabrò MP; Gagliano A
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jun; 51():23-7. PubMed ID: 24211841
[TBL] [Abstract][Full Text] [Related]
15. How effective is it to sequentially switch among Olanzapine, Quetiapine and Risperidone?--A randomized, open-label study of algorithm-based antipsychotic treatment to patients with symptomatic schizophrenia in the real-world clinical setting.
Suzuki T; Uchida H; Watanabe K; Nomura K; Takeuchi H; Tomita M; Tsunoda K; Nio S; Den R; Manki H; Tanabe A; Yagi G; Kashima H
Psychopharmacology (Berl); 2007 Dec; 195(2):285-95. PubMed ID: 17701027
[TBL] [Abstract][Full Text] [Related]
16. Comparison of effects of olanzapine and risperidone on body mass index and blood sugar level in schizophrenic patients.
Ingole S; Belorkar NR; Waradkar P; Shrivastava M
Indian J Physiol Pharmacol; 2009; 53(1):47-54. PubMed ID: 19810576
[TBL] [Abstract][Full Text] [Related]
17. [A naturalistic, observational study of outpatients with schizophrenia: efficacy and safety results after 6 months. The International Schizophrenia Outpatient Health Outcomes study, IC-SOHO].
István S; Agoston T; Tamás T; Zoltán J
Neuropsychopharmacol Hung; 2007 Oct; 9(3):115-24. PubMed ID: 18399029
[TBL] [Abstract][Full Text] [Related]
18. Increased risk of antipsychotic-related QT prolongation during nighttime: a 24-hour holter electrocardiogram recording study.
Watanabe J; Suzuki Y; Fukui N; Ono S; Sugai T; Tsuneyama N; Someya T
J Clin Psychopharmacol; 2012 Feb; 32(1):18-22. PubMed ID: 22198445
[TBL] [Abstract][Full Text] [Related]
19. An open, large, 6-month naturalistic study of outcome in schizophrenic outpatients, treated with olanzapine.
Krzystanek M; Krupka-Matuszczyk I
Hum Psychopharmacol; 2011 Jan; 26(1):81-5. PubMed ID: 23055416
[TBL] [Abstract][Full Text] [Related]
20. Effects of aripiprazole on prolactin levels in subjects with schizophrenia during cross-titration with risperidone or olanzapine: analysis of a randomized, open-label study.
Byerly MJ; Marcus RN; Tran QV; Eudicone JM; Whitehead R; Baker RA
Schizophr Res; 2009 Feb; 107(2-3):218-22. PubMed ID: 19038534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]